Protara Therapeutics, Inc. (TARA) Tops Q2 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
Tweet
Share
E-mailGet Alerts TARA Hot Sheet
Join SI Premium – FREE
Protara Therapeutics, Inc. (NASDAQ: TARA) reported Q2 EPS of ($0.35), $0.05 better than the analyst estimate of ($0.40).
For earnings history and earnings-related data on Protara Therapeutics, Inc. (TARA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SpaceX (SPCX) PT Raised to $230 at Goldman Sachs ahead of earnings release
- OpenAI In Talks With UAE Funds, Blackrock For $30 Billion Round - Bloomberg
- Northrop Grumman wins $66M Navy contract for MQ-4C Triton upgrades
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
